Uric Acid Tied to CKD Progression
Higher levels of uric acid are weakly but significantly associated with progression of kidney disease, according to researchers.
Higher levels of uric acid are weakly but significantly associated with progression of kidney disease, according to researchers.
Pentraxin 3, a mediator of inflammation, is markedly elevated in patients on hemodialysis (HD) but not in patients on peritoneal dialysis (PD) or in patients with chronic renal failure (CRF) not on dialysis, according to researchers.
Patients with membranous nephropathy (MN) are at increased risk of developing cancer, according to researchers in Norway.
Elevated BMI is associated with secondary hyperparathyroidism in non-dialysis CKD patients, especially patients who have evidence of malnutrition and inflammation, a study found.
Patients with and without diabetes respond similarly to extended dosing of epoetin alfa as infrequently as once every four weeks, data show.
Even normal portions can significantly increase serum creatinine levels, studies show.
CHICAGO—Atorvastatin (Lipitor) is as effective in preventing major cardiovascular events in type 2 diabetics who have impaired renal function as it is in those with normal renal function, according to data presented here at the 67th Scientific Sessions of the American Diabetes Association.
Combining an ACE inhibitor (ACEI) and angiotensin-receptor blocker (ARB) with enzyme replacement therapy using agalsidase-beta (Fabrazyme, Genzyme) may help stop progressive loss of kidney function in patients with severe kidney involvement due to Fabry disease, researchers report.
Decreasing levels of vitamin D are associated with increases in the prevalence in albuminuria, according to an epidemiologic study.
High ambulatory but normal or well-controlled office BP, a condition known as “reverse white-coat hypertension,” is an independent risk factor for microalbuminuria in patients with treated hypertension.